Hostname: page-component-745bb68f8f-kw2vx Total loading time: 0 Render date: 2025-01-08T12:11:09.833Z Has data issue: false hasContentIssue false

Comments on ‘Longitudinal Analysis of Patient-Reported Outcomes in Clinical Trials: Applications of Multilevel and Multidimensional Item Response Theory’

Published online by Cambridge University Press:  01 January 2025

Karl Bang Christensen*
Affiliation:
University of Copenhagen
*
Correspondence should be made to Karl Bang Christensen, Section of Biostatistics, Department of Public Health, University of Copenhagen, Kobenhavn, Denmark. Email: [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Application Reviews and Case Studies
Copyright
Copyright © 2021 The Psychometric Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barker, Steve, Horton, M, Kent, RM, Tennant, A Development of a self-report scale of spasticity. Topics in Stroke Rehabilitation, (2013). 20 (6 485 49211CrossRefGoogle ScholarPubMed
Baunsgaard, C. B., Nissen, UV, Christensen, KB, Biering-Sørensen, F Modified Ashworth scale and spasm frequency score in spinal cord injury: Reliability and correlation. Spinal Cord, (2016). 54 (9 702 7089CrossRefGoogle ScholarPubMed
Cai, L., & Houts, C. R. (2021). Longitudinal analysis of patient-reported outcomes in clinical trials: Applications of multilevel and multidimensional item response theory. Psychometrika (in press).CrossRefGoogle Scholar
Glas, CAW, Geerlings, H, van de Laar, MAFJ, Taal, E Analysis of longitudinal randomized clinical trials using item response models. Contemporary Clinical Trials, (2009). 30 (2 158 1703CrossRefGoogle ScholarPubMed
US Department of Health, Human Services, et al. Guidance for industry-patient-reported outcome measures: Use in medical product development to support labeling claims. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm, 2009.Google Scholar